IL17A and COVID-19: IL-17 has been previously shown to be amongst the cytokines increased in COVID-19 patients and to induce cardiomyocyte apoptosis.41–43 Due to the low volumes of serum we had at our disposal we were unable to perform IL-17 ELISA on our samples but we theorize that IL-17 is potentially another cytokine mediator that affects cardiomyocytes.